The Open Pharma podcast
Providing the latest on innovations in medical publishing from the pharmaceutical industry perspective
Listen on:
Episodes
Tuesday Oct 16, 2018
Tuesday Oct 16, 2018
In this first instalment of the Open Pharma podcast, we look at the benefits of open access and how best to avoid predatory publishers. We speak with Chris Winchester, CEO of Oxford PharmaGenesis and co-founder of Open Pharma, about his passion for open access and his concerns about the potential impact of predatory publishing on the dissemination of medical research. Mary Yianni, Publisher at Taylor and Francis, then gives her insights into how to spot a predatory publisher.